PVD-06
PVD-06 is a selective PROTAC PTPN2 degrader with a DC50 of 217 nM (selectivity index >60-fold over PTP1B). PVD-06 induces PTPN2 degradation via a VHL-, ubiquitin, and proteasome-dependent pathway. PVD-06 can promote T cell activation and amplify IFN-γ-mediated anticancer activity. PVD-06 can be used to further investigate PTPN2 in diseases such as leukemia and melanoma[1]. (Pink: PTPN2 ligand , Black: linker (HY-B0236), Blue: VHL ligand (HY-112078) ).
Product Specifications
CAS Number
3032975-48-4
UNSPSC
12352005
Target
IFNAR; Phosphatase; PROTACs; STAT
Type
Reference compound
Related Pathways
Immunology/Inflammation; JAK/STAT Signaling; Metabolic Enzyme/Protease; PROTAC; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pvd-06.html
Purity
98.30
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C48H55F4N9O11S2
Molecular Weight
1074.13
References & Citations
[1]Hu L et al. Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader. J Med Chem. 2023 Nov 23;66 (22) :15269-15287.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF594 conjugate, 0.1mg/mL
3,3',3''-(2,4,6-boroxintriyl)tris-Pyridine Hydrochloride (>70%)
